000 | 01151 a2200289 4500 | ||
---|---|---|---|
005 | 20250516022319.0 | ||
264 | 0 | _c20110404 | |
008 | 201104s 0 0 eng d | ||
022 | _a1532-6535 | ||
024 | 7 |
_a10.1038/clpt.2010.261 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCornely, O A | |
245 | 0 | 0 |
_aLack of evidence for exposure-response relationship in the use of posaconazole as prophylaxis against invasive fungal infections. _h[electronic resource] |
260 |
_bClinical pharmacology and therapeutics _cMar 2011 |
||
300 |
_a351-2 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMycoses _xprevention & control |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTriazoles _xadministration & dosage |
700 | 1 | _aUllmann, A J | |
773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 89 _gno. 3 _gp. 351-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2010.261 _zAvailable from publisher's website |
999 |
_c20551002 _d20551002 |